Personalized Care with DPP4i/SGLT2i Strategy as Initial-Line in the Management of Type 2 Diabetes Mellitus with Cardiovascular Risk: DELPHI Statement. ccm [Internet]. 2024 Mar. 28 [cited 2026 Sep. 17];8(2):111-7. Available from: https://fortunejournals.org/ojs/index.php/ccm/article/view/16470